SIRT1 and metabolic dysfunction-associated steatotic liver disease: Maternal HFD altered the expression of downstream effector in NAFLD by regulating SIRT1. SIRT1 maintains deacetylase activity on the peptide substrate of H3K14 acetylation in vitro.